These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27556669)

  • 1. Platelet-to-Lymphocyte Ratio and Use of NSAIDs During the Perioperative Period as Prognostic Indicators in Patients With NSCLC Undergoing Surgery.
    Lee BM; Rodriguez A; Mena G; Gottumukkala V; Mehran RJ; Rice DC; Feng L; Yu J; Cata JP
    Cancer Control; 2016 Jul; 23(3):284-94. PubMed ID: 27556669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.
    Choi JE; Villarreal J; Lasala J; Gottumukkala V; Mehran RJ; Rice D; Yu J; Feng L; Cata JP
    Cancer Med; 2015 Jun; 4(6):825-33. PubMed ID: 25756351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
    Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
    Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer.
    Jiang W; Wang L; Zhang J; Shen H; Dong W; Zhang T; Li X; Wang K; Du J
    Medicine (Baltimore); 2018 Sep; 97(39):e12442. PubMed ID: 30278522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative platelet to lymphocyte and neutrophil to lymphocyte ratios are independent prognostic factors for patients undergoing lung cancer radical surgery: A single institutional cohort study.
    Lan H; Zhou L; Chi D; Zhou Q; Tang X; Zhu D; Yue J; Liu B
    Oncotarget; 2017 May; 8(21):35301-35310. PubMed ID: 27845912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
    Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
    Wang G; Ma W; Li Y; Jiang Y; Ma G; Zhang X; Meng L; Du J
    Eur J Cardiothorac Surg; 2018 Aug; 54(2):237-245. PubMed ID: 29415155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
    Kim SH; Lee HW; Go SI; Lee SI; Lee GW
    Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High platelet-to-lymphocyte ratio predicts improved survival outcome for perioperative NSAID use in patients with rectal cancer.
    Huang Z; Wang X; Zou Q; Zhuang Z; Xie Y; Cai D; Bai L; Tang G; Huang M; Luo Y; Yu H
    Int J Colorectal Dis; 2020 Apr; 35(4):695-704. PubMed ID: 32040733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yılmaz U; Ozdemir O; Batum O; Ermin S
    Indian J Cancer; 2018; 55(3):276-281. PubMed ID: 30693894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.
    Sarraf KM; Belcher E; Raevsky E; Nicholson AG; Goldstraw P; Lim E
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):425-8. PubMed ID: 19185164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of platelet-to-lymphocyte ratıo (PLR) and glasgow prognostıc score (GPS) on recurrence, and survıval ın patıents undergoıng lobectomy for early-stage non-small cell lung cancer (NSCLC).
    Agaoglu Sanli B; Gulmez B; Yazgan S; Ucvet A
    Updates Surg; 2024 Apr; 76(2):631-639. PubMed ID: 37853294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
    Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
    Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.